News
Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Most dividend yields ...
Once the golden child of the weight-loss boom, the Danish drugmaker now faces a painful financial slimming of its own.
Hims & Hers continues to spend heavily on marketing to attract new customers. During the quarter, its marketing spending ...
WEIGHT-LOSS drugs can be a silver bullet for some trying to shed the pounds after years of failure with fad diets and exercise routines. But dodgy vendors selling potentially deadly fake jabs ...
22h
MarketBeat on MSNTrump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli LillyThis week, drugmakers had a scare when President Trump threatened to levy tariffs of up to 250% on imported pharmaceuticals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results